Patents by Inventor RONG-KUNG TSAI

RONG-KUNG TSAI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR TREATING OPTIC NEUROPATHY
    Publication number: 20240058419
    Abstract: Provided is a pharmaceutical composition for treating optic neuropathy, including a long-acting granulocyte-colony stimulating factor (G-CSF) and a pharmaceutically acceptable excipient thereof. Also provided is a method for treating optic neuropathy in a subject in need thereof, including administering to the subject with the long-acting G-CSF.
    Type: Application
    Filed: August 22, 2022
    Publication date: February 22, 2024
    Inventors: Rong-Kung TSAI, Yao-Tseng WEN
  • METHOD FOR PROVIDING OCULAR NEUROPROTECTION OR FOR PREVENTING, TREATING OR ALLEVIATING THE EFFECTS OF, AN OCULAR DISEASE ASSOCIATED WITH RETINAL GANGLION CELL DEATH
    Publication number: 20190388548
    Abstract: The present invention relates to a method for providing ocular neuroprotection or for preventing, treating or alleviating the effects of, an ocular disease associated with retinal ganglion cell death in a subject in need thereof, comprising administering to said subject an effective amount of a recombinant P-selectin immunoglobin G (P-sel-IgG) chimeric fusion protein, or a composition comprising the protein and a pharmaceutically acceptable adjuvant, vehicle, or carrier.
    Type: Application
    Filed: June 26, 2018
    Publication date: December 26, 2019
    Applicant: TZU CHI UNIVERSITY
    Inventors: Shun-Ping Huang, Rong-Kung Tsai
  • Method of treating or preventing the visual function loss by using 4-(phenylsulfanyl)butane-2-one (4-PSB-2)
    Patent number: 9907763
    Abstract: The present invention relates to a method of treating or preventing the visual function loss in optic nerve in a subject after crush injury by using 4-(Phenylsulfanyl)butane-2-one (4-PSB-2). The present invention has the ability of enhancing the protection effect of RGCs, preserving the visual function in optic nerve after crush injury, recovering the visual function loss, attenuating apoptosis in optic nerve after injury, and inhibiting the inflammatory responses in optic nerves after ON injury.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: March 6, 2018
    Assignee: NATIONAL SUN YAT-SEN UNIVERSITY
    Inventors: Shun-Ping Huang, Jyh-Horng Sheu, Zhi-Hong Wen, Rong-Kung Tsai
  • METHOD OF TREATING OR PREVENTING THE VISUAL FUNCTION LOSS BY USING 4-(PHENYLSULFANYL)BUTANE-2-ONE (4-PSB-2)
    Publication number: 20170304219
    Abstract: The present invention relates to a method of treating or preventing the visual function loss in optic nerve in a subject after crush injury by using 4-(Phenylsulfanyl)butane-2-one (4-PSB-2). The present invention has the ability of enhancing the protection effect of RGCs, preserving the visual function in optic nerve after crush injury, recovering the visual function loss, attenuating apoptosis in optic nerve after injury, and inhibiting the inflammatory responses in optic nerves after ON injury.
    Type: Application
    Filed: October 21, 2016
    Publication date: October 26, 2017
    Applicants: NATIONAL SUN YAT-SEN UNIVERSITY, TZU-CHI UNIVERSITY
    Inventors: SHUN-PING HUANG, JYH-HORNG SHEU, ZHI-HONG WEN, RONG-KUNG TSAI